Growth of a meningioma in a transsexual patient after estrogen-progestin therapy [19]

New England Journal of Medicine

Volumn 357, Issue 23, 2007, Pages 2411-2412

  Gazzeri, Roberto ^a   Galarza, Marcelo ^a   Gazzeri, Giovanni ^b  

^a SAN GIOVANNI ADDOLORATA HOSPITAL   (Italy)

^b SAN FILIPPO NERI HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYPROTERONE ACETATE; ESTRADIOL UNDECYLATE; ETHINYLESTRADIOL; PROLACTIN;

ADULT; CASE REPORT; CLINICAL EXAMINATION; CONFUSION; DISEASE SEVERITY; EUPHORIA; FOLLOW UP; GENDER IDENTITY; GONADECTOMY; HEADACHE; HISTOPATHOLOGY; HORMONE SUBSTITUTION; HOSPITAL ADMISSION; HUMAN; LETTER; MALE; MENINGIOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NERVE ATROPHY; PAPILLEDEMA; PERSONALITY DISORDER; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; SEX TRANSFORMATION; TRANSSEXUALISM; TREATMENT OUTCOME; VISUAL DISORDER; VISUAL FIELD DEFECT; VISUAL IMPAIRMENT;

EID: 36849004490     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc071938     Document Type: Letter

References (5)

1. Moore E, Wisniewski A, Dobs A. Endocrine treatment of transsexual people: a review of treatment regimens, outcomes, and adverse effects. J Clin Endocrinol Metab 2003;88:3467-73.
2. Pritchard TJ, Pankowsky DA, Crowe JP, Abdul-Karim FW. Breast cancer in a male-to-female transsexual: a case report. JAMA 1988;259:2278-80.
3. Serri O, Noiseux D, Robert F, Hardy J. Lactotroph hyperplasia in an estrogen treated male-to-female transsexual patient. J Clin Endocrinol Metab 1996;81:3177-9.
4. Kovacs K, Stefaneanu L, Ezzat S, Smyth HS. Prolactin-producing pituitary adenoma in a male-to-female transsexual patient with protracted estrogen administration: a morphologic study. Arch Pathol Lab Med 1994;118:562-5.
5. Wigertz A, Lönn S, Mathiesen T, Ahlbom A, Hall P, Feychting M. Risk of brain tumors associated with exposure to exogenous female sex hormones. Am J Epidemiol 2006;164:629-36.